Growth Metrics

Gossamer Bio (GOSS) Cash from Investing Activities: 2022-2025

Historic Cash from Investing Activities for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $17.0 million.

  • Gossamer Bio's Cash from Investing Activities rose 163.59% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.4 million, marking a year-over-year increase of 453.79%. This contributed to the annual value of $29.0 million for FY2024, which is 126.15% up from last year.
  • As of Q3 2025, Gossamer Bio's Cash from Investing Activities stood at $17.0 million, which was down 61.44% from $44.1 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Cash from Investing Activities peaked at $61.7 million during Q1 2024, and registered a low of -$118.3 million during Q3 2023.
  • Moreover, its 3-year median value for Cash from Investing Activities was $12.9 million (2023), whereas its average is $114,091.
  • Examining YoY changes over the last 5 years, Gossamer Bio's Cash from Investing Activities showed a top increase of 607.10% in 2024 and a maximum decrease of 556.96% in 2024.
  • Quarterly analysis of 4 years shows Gossamer Bio's Cash from Investing Activities stood at $8.5 million in 2022, then plummeted by 269.73% to -$14.4 million in 2023, then soared by 470.43% to $53.2 million in 2024, then soared by 163.59% to $17.0 million in 2025.
  • Its Cash from Investing Activities was $17.0 million in Q3 2025, compared to $44.1 million in Q2 2025 and $22.1 million in Q1 2025.